Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

Klinik und Poliklinik für Kinder- und Jugendmedizin

Klinikum / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10


Muenzer, J; Bodamer, O; Burton, B et al.

The role of enzyme replacement therapy in severe Hunter syndrome-an expert panel consensus

EUROPEAN JOURNAL OF PEDIATRICS. Bd. 171. H. 1. 2012 S. 181-188


Hoppe, F.; Knuf, M.

Tonsillectomy and tonsillotomy. ENT surgeon and pediatric viewpoints

MONATSSCHRIFT KINDERHEILKUNDE. Bd. 160. H. 12. 2012 S. 1251-1263


Siuda, D; Zechner, U; Prawitt, D et al.

Transcriptional regulation of Nox4 by histone deacetylases

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 385. 2012 S. 91-91


Siuda, D; Zechner, U; El Hajj, N et al.

Transcriptional regulation of Nox4 by histone deacetylases in human endothelial cells

BASIC RESEARCH IN CARDIOLOGY. Bd. 107. H. 5. 2012 S. -


Ganser, G.; Klimek, R.; Illhardt, A. et al.

Transitional concepts for juvenile idiopathic arthritis. Planning the transition from pediatric care to management by internists specialized in rheumatology

MONATSSCHRIFT KINDERHEILKUNDE. Bd. 160. H. 3. 2012 S. 231-236


Patterson, M; Pineda, M; Mengel, E et al.

Update From the International Registry for Niemann-Pick Disease Type C (NP-C) in Clinical Practice

MOLECULAR GENETICS AND METABOLISM. Bd. 105. H. 2. 2012 S. S51-S51


Moos, L; Reinke, J; Brixius-Huth, M et al.

Whole body MRI technique in early treated non-neuronopathic patients with enzyme replacement therapy at least eight years

Book of Abstracts, 1oth European Working Group on Gaucher Diseases. 2012 S. 48


Winter, J; Hiort, O; Hermanns, P et al.

A new heterozygous mutation (D196N) in the Gs alpha gene as a cause for pseudohypoparathyroidism type IA in a boy who had gallstones

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM. Bd. 24. H. 5-6. 2011 S. 297-301


Weinreb, N; Belmatoug, N; Bembi, B et al.

A novel tool for mapping disease severity and outcomes in patients with Gaucher disease utilising the therapeutic goals

MOLECULAR GENETICS AND METABOLISM. Bd. 102. H. 2. 2011 S. S46-S46